People Background Check
Find People:

Jayanthi S Rajagopalan, Age 63301 Accolade Dr, Cary, NC 27513

Get Report
Known as:
Jayanthi S R Ramaswamy Jayanthi S Ramaswamy Jay Rajagopalan Jayanthi Rajapopalan Ramaswamy Jayanthi
Related to:
Arvind Ramaswamy

Jayanthi Rajagopalan Phones & Addresses

301 Accolade Dr, Cary, NC 27513 (919) 468-8666

Washington, DC

Durham, NC

Burbank, CA

Cheltenham, PA

Milwaukee, WI

301 Accolade Dr, Cary, NC 27513 (919) 225-3675

Show more

Work

Position: Food Preparation and Serving Related Occupations

Mentions for Jayanthi S Rajagopalan

Publications & IP owners

Us Patents

Drug-Oligomer Conjugates With Polyethylene Glycol Components

US Patent:
7030084, Apr 18, 2006
Filed:
Feb 10, 2004
Appl. No.:
10/774903
Inventors:
Nnochiri N. Ekwuribe - Cary NC, US
Muthukumar Ramaswamy - Cary NC, US
Jayanthi Rajagopalan - Cary NC, US
Assignee:
Nobex Corporation - Durham NC
International Classification:
A61K 38/28
C07K 14/62
A61K 38/02
C07K 2/00
US Classification:
514 3, 514 2, 514 21, 530303, 530345, 530410
Abstract:
The present invention relates generally to hydrolyzable drug-oligomer conjugates, pharmaceutical compositions comprising such conjugates, and to methods for making and using such conjugates and pharmaceutical compositions. For example, a conjugate of insulin, PEG, and oleic acid can be orally administered.

Insulin Prodrugs Hydrolyzable In Vivo To Yield Peglylated Insulin

US Patent:
7169889, Jan 30, 2007
Filed:
Jun 19, 2000
Appl. No.:
10/018879
Inventors:
Nnochiri N. Ekwuribe - Cary NC, US
Muthukumar Ramaswamy - Cary NC, US
Jayanthi Rajagopalan - Cary NC, US
Assignee:
Biocon Limited - Bangalore
International Classification:
A61K 38/28
C07K 14/62
US Classification:
530303, 514 3
Abstract:
The present invention relates generally to hydrolyzable drug-oligomer conjugates, pharmaceutical compositions comprising such conjugates, and to methods for making and using such conjugates and pharmaceutical compositions. For example, a conjugate of insulin, PEG, and oleic acid can be orally administered.

Amphiphilic Drug-Oligomer Conjugates With Hydroyzable Lipophile Components And Methods For Making And Using The Same

US Patent:
6309633, Oct 30, 2001
Filed:
Jun 19, 1999
Appl. No.:
9/336548
Inventors:
Nnochiri Ekwuribe - Cary NC
Muthukumar Ramaswamy - Cary NC
Jayanthi Sethuraman Rajagopalan - Cary NC
Assignee:
Nobex Corporation - Research Triangle Park NC
International Classification:
A61K 9107
A61K 3817
A61K 3828
A61K 39385
C07K 1113
US Classification:
424 851
Abstract:
The invention provides a drug-oligomer conjugate having the following general formula: ##STR1## wherein D is a therapeutic drug moiety; H and H' are each a hydrophilic moiety, independently selected from the group consisting of straight or branched PEG polymers having from 2 to 130 PEG subunits, and sugars; L is a lipophilic moiety selected from the group consisting of alkyl groups having 2-26 carbon atoms, cholesterol, adamantane and fatty acids; o is a number from 1 to the maximum number of covalent bonding sites on H; m+n+p together have a value of at least one and not exceeding the total number of covalent bonding sites on D for the --H', --L and --H--L substituents; the H--L bond(s) are hydrolyzable and the D--L' bond(s), when present, are hydrolyzable; the conjugate being further characterized by one of the following: (i) m is 0 and p is at least 1; (ii) n is 0 and p is at least 1; (iii) m and n are each 0 and p is at least 1; (iv) p is 0 and m and n are each at least 1. The therapeutic drug moiety is preferably a therapeutic protein or peptide, preferably insulin or a functional equivalent thereof.

Possible Relatives

Ganesh Rajagopalan  Geetha Rajagopalan  Kannan Rajagopalan  Kavitha K Rajagopalan  Keshav Rajagopalan  Krishnan Rajagopalan  Murali K Rajagopalan 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.